93 related articles for article (PubMed ID: 38641823)
1. Plasmodium yoelii Infection Enhances the Expansion of Myeloid-Derived Suppressor Cells via JAK/STAT3 Pathway.
Zhu Y; Zhou L; Mo L; Hong C; Pan L; Lin J; Qi Y; Tan S; Qian M; Hu T; Zhao Y; Qiu H; Lin P; Ma X; Yang Q
J Immunol; 2024 May; ():. PubMed ID: 38819229
[TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer.
Ko HJ; Kim YJ
Arch Pharm Res; 2016 Nov; 39(11):1597-1608. PubMed ID: 27572156
[TBL] [Abstract][Full Text] [Related]
3. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
[TBL] [Abstract][Full Text] [Related]
4. Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway.
Zhang Y; Lei Y; Ou Q; Chen M; Tian S; Tang J; Li R; Liang Q; Chen Z; Wang C
BMC Biol; 2024 Apr; 22(1):88. PubMed ID: 38641823
[TBL] [Abstract][Full Text] [Related]
5. Preimmunization with Listeria-vectored cervical cancer vaccine candidate strains can establish specific T-cell immune memory and prevent tumorigenesis.
Zhang Y; Liu S; Chen M; Ou Q; Tian S; Tang J; He Z; Chen Z; Wang C
BMC Cancer; 2024 Mar; 24(1):288. PubMed ID: 38439023
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer.
Jianyi D; Haili G; Bo Y; Meiqin Y; Baoyou H; Haoran H; Fang L; Qingliang Z; Lingfei H
Cancer Immunol Immunother; 2023 Jan; 72(1):73-85. PubMed ID: 35725835
[TBL] [Abstract][Full Text] [Related]
7. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
[TBL] [Abstract][Full Text] [Related]
8. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
Front Immunol; 2020; 11():613215. PubMed ID: 33679700
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6
Jiang M; Chen J; Zhang W; Zhang R; Ye Y; Liu P; Yu W; Wei F; Ren X; Yu J
Front Immunol; 2017; 8():1840. PubMed ID: 29326716
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy for targeting the immune system in cervical cancer patients.
Linares I; Berenguer Frances MÁ; Cañas R; Najjari D; Gutiérrez C; Marín S; Comas S; Guedea F; Pujol M
BMC Immunol; 2023 Aug; 24(1):23. PubMed ID: 37559025
[TBL] [Abstract][Full Text] [Related]
11. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis.
King RJ; Shukla SK; He C; Vernucci E; Thakur R; Attri KS; Dasgupta A; Chaika NV; Mulder SE; Abrego J; Murthy D; Gunda V; Pacheco CG; Grandgenett PM; Lazenby AJ; Hollingsworth MA; Yu F; Mehla K; Singh PK
Oncogene; 2022 Feb; 41(7):971-982. PubMed ID: 35001076
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study.
Yi M; Li T; Niu M; Luo S; Chu Q; Wu K
Biomark Res; 2021 Jul; 9(1):55. PubMed ID: 34233747
[TBL] [Abstract][Full Text] [Related]
13. Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model.
Su L; Zhang Y; Zhang X; Liu T; Liu S; Li Y; Jiang M; Tang T; Shen H; Wang C
Sci Rep; 2021 Jun; 11(1):13404. PubMed ID: 34183739
[TBL] [Abstract][Full Text] [Related]
14. The immune landscape during the tumorigenesis of cervical cancer.
Wang Y; He M; Zhang G; Cao K; Yang M; Zhang H; Liu H
Cancer Med; 2021 Apr; 10(7):2380-2395. PubMed ID: 33694292
[TBL] [Abstract][Full Text] [Related]
15. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy.
Weber R; Groth C; Lasser S; Arkhypov I; Petrova V; Altevogt P; Utikal J; Umansky V
Cell Immunol; 2021 Jan; 359():104254. PubMed ID: 33296753
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
